Treatment of walking impairment in multiple sclerosis: an unmet need for a disease-specific disability

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.12, Iss.10, 2011-07, pp. : 1511-1521

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of cognitive impairment in patients with multiple sclerosis

By Patti Francesco

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 11, 2012-11 ,pp. : 1679-1699

Informa Healthcare

Access to resources Recommend Favorite

Improve treatment of multiple sclerosis by defining specific pain syndromes and analysing their relationship to the disease

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 25, Iss. 1, 2009-01 ,pp. : 14-17

Adis International

Access to resources Recommend Favorite

Specific Immune Intervention with Monoclonal Antibodies for the Treatment of Multiple Sclerosis

Current Medicinal Chemistry, Vol. 17, Iss. 7, 2010-03 ,pp. : 640-650

Bentham Science Publishers

Access to resources Recommend Favorite

The Cost of Multiple Sclerosis and the Cost Effectiveness of Disease-Modifying Agents in its Treatment

By Phillips C.J.

CNS Drugs, Vol. 18, Iss. 9, 2004-01 ,pp. : 561-574

Adis International

Access to resources Recommend Favorite

Disease-Modifying Agents in the Treatment of Multiple Sclerosis: A Review of Long-Term Outcomes

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 8, Iss. 6, 2009-12 ,pp. : 512-519

Bentham Science Publishers

Access to resources Recommend Favorite